Primary Insomnia Clinical Trial
— dietOfficial title:
The Effects of Milk and Banana Given as a Night Meal to Individuals Diagnosed With Sleep Disorders on Sleep Quality, BDNF and Appetite Mechanism
NCT number | NCT05420090 |
Other study ID # | 0001 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | June 1, 2022 |
Est. completion date | June 30, 2023 |
Verified date | July 2023 |
Source | Saglik Bilimleri Universitesi |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of this study to determine the impact of banana and milk on sleep and appetite
Status | Completed |
Enrollment | 21 |
Est. completion date | June 30, 2023 |
Est. primary completion date | May 30, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 45 Years |
Eligibility | Inclusion Criteria: - Applying to the Sleep Polyclinic, - 18-45 years old, - Body Mass Index (BMI) between 18.5-25 kg/m2, - Male and female patients diagnosed with primary sleep disorder for the first time Exclusion Criteria: - Individuals with any psychiatric illness, - Those who use cigarettes, alcohol, drugs or sedative drugs, - Individuals with any chronic disease (diabetes, etc.), - Pregnant and/or lactating - Individuals with lactose intolerance, - athletes, - Individuals who are allergic to bananas - Individuals with lactose intolerance or milk intolerance |
Country | Name | City | State |
---|---|---|---|
Turkey | Selcuk University Medical Faculty | Konya |
Lead Sponsor | Collaborator |
---|---|
Saglik Bilimleri Universitesi |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Changing Score on the Pittsburgh Sleep Quality Index (PSQI) from baseline | Change from baseline PSQI at 6 weeks | at baseline, 6. week | |
Primary | Level of Brain Derived Neurotrophic Factor (pg/ml) | Fasting (less than 12 hrs) venous blood samples were collected from all the participants and centrifugation of the specimen was done (ng/ml) | at baseline, 6. week | |
Primary | Level of Leptin (mg/dl) | Fasting (less than 12 hrs) venous blood samples were collected from all the participants and centrifugation of the specimen was done (ng/ml) | at baseline, 6. week | |
Primary | Level of Ghrelin (mg/dl) | Fasting (less than 12 hrs) venous blood samples were collected from all the participants and centrifugation of the specimen was done (ng/ml)) | at baseline and 6. week | |
Primary | Evaluate stages of sleep and the oxygen level in blood | Polymsomnography is used for the diagnosis and treatment plan of sleep disorder and sleep architecture | at baseline and 6. week | |
Secondary | Nutrient intake (g/day) | assessed by a food frequency record as g/day | 6 consecutive weeks, 6 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03461666 -
Comparison of Efficacy of Behavioral Approaches for Treatment of Insomnia
|
N/A | |
Recruiting |
NCT02243501 -
Better Nights, Better Days for Typically Developing Children
|
N/A | |
Completed |
NCT01636791 -
CBT Versus a Return to Work Intervention for Patients With Common Mental Illness in Primary Care
|
Phase 3 | |
Completed |
NCT00770510 -
A Phase II/III Study of SEP-190 (Eszopiclone) in Patients With Primary Insomnia (Study 190-126)
|
Phase 2/Phase 3 | |
Completed |
NCT00520832 -
A Pilot Study Of The Effects Of Microcurrent On Three Sleep Surveys
|
Phase 2 | |
Recruiting |
NCT00415714 -
Safety and Efficacy of an Ambulatory Biofeedback Device for Primary Insomnia
|
N/A | |
Terminated |
NCT00420810 -
Adult Polysomnography Primary Insomnia Cross Over Study (0928-049)(TERMINATED)
|
Phase 3 | |
Completed |
NCT00178048 -
Paroxetine in the Treatment of Chronic Primary Insomnia
|
Phase 4 | |
Completed |
NCT00816673 -
Sleep Inducing And Maintaining Efficacy Of Circadin In Elderly Insomniacs
|
Phase 2 | |
Completed |
NCT01960452 -
A High Density EEG Comparison of Sleep Patterns in Insomnia
|
N/A | |
Completed |
NCT01957111 -
Metabolomics of Insomnia-Related Hyperarousal
|
N/A | |
Completed |
NCT01181232 -
A Study to Compare Efficacy and Safety of Zolpidem Modified Release Formulation Versus Zolpidem in Insomnia Patients
|
Phase 4 | |
Completed |
NCT00784875 -
An Efficacy Study of Compound LY2624803 in the Treatment of Patients With Chronic Insomnia
|
Phase 2 | |
Completed |
NCT00551148 -
A Dose-ranging, Multicenter Polysomnography Trial of PD 0200390 in Adults With Primary Insomnia
|
Phase 2 | |
Completed |
NCT00397189 -
Efficacy and Safety of Circadin® 2 mg in the Treatment of Primary Insomnia Patients
|
Phase 3 | |
Completed |
NCT00352144 -
6-Month Chronic Efficacy & Safety Study of Eszopiclone in Adult Subjects With Primary Insomnia
|
Phase 3 | |
Completed |
NCT02290405 -
Impact of Hyperarousal on Simple and Complex Cognitive Task Performance Among Insomnia Sufferers
|
||
Completed |
NCT03314441 -
Effects of Regular Practice of Yoga on Subjective and Objective Sleep Quality in Primary Insomnia
|
N/A | |
Completed |
NCT00792298 -
Phase IIB 2-Period Crossover Polysomnography Study in Participants With Primary Insomnia (MK-4305-006)
|
Phase 2 | |
Completed |
NCT01021852 -
Polysomnography Study of MK-6096 in Participants With Primary Insomnia (MK-6096-011)
|
Phase 2 |